Citation

Daniel Johnson, M.D., Elizabeth (Betsy) J. McFarland, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., James McNamara, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Elizabeth Hawkins, Pamela Bouquin, B.A., Scharla Estep, M.S., R.Ph., Georgia D. Tomaras, Ph.D., Carol A. Vincent, C.R.N.P., M.S.N, Mobeen H. Rathore, M.D., Ann J. Melvin, M.D., M.P.H., Sanjay Gurunathan, M.D., John S. Lambert, M.D. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women. Journal of Infectious Diseases. 2005 Dec 15; 192(12):2129-2133.

Citation

John S. Lambert, M.D., John ( Jack ) Moye, Jr., M.D., Susan Plaeger, Ph.D., E. Richard Stiehm, M.D., James Bethel, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Bonnie J. Mathieson, Ph.D., Jonathan Kagan, Ph.D., Howard Max Rosenblatt, M.D., Helene M.A. Paxton, M.S., M.T., Hildie Suter, B.S., Alan Landay, Ph.D. Association of selected phenotypic markers of lymphocyte activation and differentiation with perinatal human immunodeficiency virus transmission and infant infection. Clinical and Diagnostic Laboratory Immunology. 2005 Sep 16; 12(5):622-631.

Citation

Luis J. Montaner, D.Phil., James Alasdair McIntyre, M.D., Charles van der Horst, M.D., Ian M. Sanne, M.D., FCP (medicine), DTM&H. Change in US research policies and directives are needed to remove barriers on HIV-1 operational research programs in developing countries: A case report of two NIH clinical trials in South Africa. Harvard Health Policy Review. 2005 Mar 20; 6(1):114-123.

Citation

Valentina Stosor, Frank Palella, M.D., Baiba Berzins, M.P.H., Michelle Till, M.D., Angel Leake, Joan S. Chmiel, Robert L. Murphy, M.D. Transient viremia in HIV-infected patients and use of plasma preparation tubes. Clinical Infectious Diseases. 2005 Dec 01; 14:1671-4.

Citation

Pachamuthu (Bala) Balakrishnan, Ph.D., Nagalingeshwaran Kumarasamy, M.B.B.S., Ph.D., Rami Kantor, M.D., Suniti (Daralak) Solomon, M.D., Kenneth H. Mayer, M.D., David Katzenstein, M.D., Bharat Ramratnam, M.D. HIV type 1 genotypic variation in an antiretroviral treatement-naive population in Southern India. AIDS Research and Human Retroviruses. 2005 Apr 01; 21(4):301-5.

Citation

Robert Shafer, M.D., Jonathan M. Schapiro. Drug resistance and antiretroviral drug development. Journal of Antimicrobial Chemotherapy. 2005 Jun 01; 55(6):817-20.

Citation

Hulin Wu, Ph.D. Statistical methods for HIV dynamic studies in AIDS clinical trials. Statistical Methods In Medical Research. 2005 Apr 01; 14(2):171-92.

Citation

Rupinderjeet J. Kaur, V. Klichko, David M. Margolis, M.D. Ex vivo modeling of the effects of mycophenolic acid on HIV infection: considerations for antiviral therapy. AIDS Research and Human Retroviruses. 2005 Feb 01; 21(2):116-24.

Citation

Samir K. Gupta, M.D., Joseph A. Eustace, M.B., M.H.S., Jonathan A. Winston, M.D., Ivy I. Boydstun, M.D., Tejinder S. Ahuja, M.B.B.S., Rudolph Rodriguez, M.D., Karen T. Tashima, M.D., Michelle E. Roland, M.D., Nora Franceschini, M.D., M.P.H., Frank Palella, M.D., Jeffrey L. Lennox, M.D., Paul E. Klotman, M.D., Sharon Appelbaum Nachman, M.D., Stephen D Hall, Ph.D., Lynda Anne Szczech, M.D., M.S.C.E. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 2005 Jun 01; 40(11):1559-85.

Citation

Eric S Daar, M.D., Karen L. Kesler, Terri Wrin, Christos J. Petropoulos, Ph.D., Michael P. Bates, M.D., Alice Lail, Nicholas S. Hellmann, M.D., Edward Gomperts, M.D., Sharyne Donfield, Ph.D. HIV-1 pol replication capacity predicts disease progression. AIDS. 2005 Jun 10; 19(9):871-7.